Navigation Links
Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock

Leader in consumer probiotics expands into livestock industry with Direct Fed Microbial offering.

MAYFIELD HEIGHTS, Ohio, June 22 /PRNewswire/ -- Ganeden Biotech, Inc., the largest seller of over-the-counter probiotics in the U.S., today announced the launch of GanPro(TM), an all-natural animal feed additive containing a direct-fed microbial (DFM) that has been shown to support gut health and naturally promote feed conversion in livestock.

Enhanced with one of Ganeden Biotech's patented strains of Bacillus coagulans, GanPro survives pelleting and other manufacturing processes as well as the harsh stomach environment of the animal. GanPro delivers consistent results, is cost-effective and is easier to use than many other DFM and lactic acid bacteria (LAB) products because, unlike many DFM and LAB products, it can be mixed directly with animal feed, does not need to be administered separately and does not require refrigeration. GanPro is appropriate for livestock of all ages. Recommended feeding rates per head are: 36 grams per day for cattle; 5.5 grams per day for pigs; and 1 gram per day for chickens. The product, which is sold directly by Ganeden Biotech, is available in bulk quantities and 50-pound bags.

The bacterial strain in GanPro has been shown to:

  • improve feed conversion ratios by increasing daily weight gain
  • increase immune system response
  • maintain the balance between good and bad gut bacteria

"Ganeden Biotech is proud to introduce GanPro as a cost-effective solution for livestock farmers who are looking for safe ways to improve feed conversion ratios and naturally improve livestock health," said Devon Durkee, Ph.D., technical account manager at Ganeden Biotech. "Because the probiotic strain used in GanPro is highly viable and able to survive in an animal's digestive tract, it is a great alternative to more traditional DFMs."

Probiotics, known as direct-fed microbials, or DFMs, in the animal nutrition industry, are good bacteria that have been shown to improve both digestive and immune health in animals. The protective nature of the Bacillus coagulans strain used in GanPro allows the bacteria to survive harsh manufacturing processes and the stomach environments of the animals to reach their digestive tract where they can grow creating the maximum benefit to the animal.

"We're excited to enter the farming and livestock production industry with GanPro," said Andy Lefkowitz, Ganeden Biotech's CEO. "This innovative product provides farmers and ranchers with a natural and effective way to improve livestock health and positively influence feed conversion without the use of antibiotics."

About Ganeden Biotech, Inc.

Established in 2006, Ganeden Labs is the licensing and development division of Ganeden Biotech, the largest seller of over-the-counter probiotic bacteria in the United States. Ganeden Labs makes proprietary, patented probiotic technology available for use in innovative products in a wide range of industries. Ganeden Labs also maintains an extensive intellectual property portfolio with patent and trademark protection for an array of technologies all over the world. Ganeden Biotech's various strains of Bacillus coagulans and its related patents are available for license in functional foods and beverages, supplements, animal health products and topical applications.

SOURCE Ganeden Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
2. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
3. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
4. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
5. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
6. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
10. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
11. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):